[HTML][HTML] Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled …

…, N Borthwick, T Bower, A Boyd, T Brenner, PD Bright… - The Lancet, 2020 - thelancet.com
Background The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
might be curtailed by vaccination. We assessed the safety, reactogenicity, and …

Recommendations for the management of secondary hypogammaglobulinaemia due to B cell targeted therapies in autoimmune rheumatic diseases

…, DR Jayne, C Mukhtyar, A Ala, PD Bright… - …, 2019 - academic.oup.com
Objectives The association of B cell targeted therapies with development of
hypogammaglobulinaemia and infection is increasingly recognized. Our aim was to develop …

Estimating the COVID-19 epidemic trajectory and hospital capacity requirements in South West England: a mathematical modelling framework

…, L Vass, KJ Looker, C Hyams, PD Bright… - BMJ open, 2021 - bmjopen.bmj.com
Objectives To develop a regional model of COVID-19 dynamics for use in estimating the
number of infections, deaths and required acute and intensive care (IC) beds using the South …

[HTML][HTML] False interpretation of diagnostic serology tests for patients treated with pooled human immunoglobulin G infusions: a trap for the unwary

PD Bright, L Smith, J Usher, M Donati… - Clinical …, 2015 - ncbi.nlm.nih.gov
Therapeutic immunoglobulin G (IgG) products are produced from numerous plasma donations,
and are infused in many medical conditions. The serological testing of patients who have …

Successful oral treatment of Ganciclovir resistant cytomegalovirus with Maribavir in the context of primary immunodeficiency: First case report and review.

PD Bright, M Gompels, M Donati… - Journal of Clinical …, 2016 - europepmc.org
Bright PD,… Schreiber A, Harter G, Schubert A, Bunjes D, Mertens T, Michel D … Marty FM,
Winston DJ, Rowley SD, Vance E, Papanicolaou GA, Mullane KM, Brundage TM, Robertson AT …

[HTML][HTML] COVID-19 vaccine allergy advice and guidance: The experience of a UK tertiary referral centre

…, N Tsiougkos, A Grammatikos, PD Bright… - World Allergy …, 2023 - Elsevier
Objective The objective was to review COVID-19 vaccine allergy advice and guidance
requests received and assess the impact of advice outcome on vaccination outcome. Design A …

[HTML][HTML] The treatment of a pregnant HIV positive patient with cryptococcal meningitis in Malawi. Case report and review of treatment options

PD Bright, D Lupiya, JJ van Oosterhout, A Chen… - Medical mycology case …, 2018 - Elsevier
This case reports cryptococcal meningitis in an HIV positive woman on antiretroviral therapy,
presenting with left middle cerebral artery stroke at 30 weeks gestation. The patient had well…

The ethics surrounding HIV, kidney donation and patient confidentiality

PD Bright, J Nutt - Journal of medical ethics, 2009 - jme.bmj.com
For live-related kidney donation, the current UK guidance specifies that the donor has a
right to know the recipient’s HIV status. This guidance may prevent some potential recipients …

Characterizing K2 planet discoveries: a super-Earth transiting the bright K dwarf HIP 116454

…, DF Phillips, G Piotto, D Pollacco… - The Astrophysical …, 2015 - iopscience.iop.org
… The secondary star falls on a diffraction spike caused by the much brighter primary star, but
… that it is blended in the K2 image and is bright enough that if it were a totally eclipsing binary, …

HARPS-N solar RVs are dominated by large, bright magnetic regions

TW Milbourne, RD Haywood, DF Phillips… - The Astrophysical …, 2019 - iopscience.iop.org
State-of-the-art radial-velocity (RV) exoplanet searches are currently limited by RV signals
arising from stellar magnetic activity. We analyze solar observations acquired over a 3 yr …